US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of ...

Merck on Thursday said any changes to the U.S. child and adolescent immunization schedule should rest on comprehensive data ...

Merck stock surges 30% on strong fundamentals, regulatory catalysts, and attractive valuation. See why I rate the MRK stock a ...

Revolution Medicines (RVMD) stock jumped 5% after a report that Merck (MRK) is in talks to buy the cancer drugmaker.

Merck & Co., Inc. (NYSE:MRK) is included among the 12 Best DOW Stocks to Buy in 2026. On January 5, Wells Fargo added Merck & ...

Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times ...

Merck & Co. is in talks to acquire the cancer-focused biotech company Revolution Medicines Inc., according to a report in the ...

RAHWAY, N.J. - Merck is officially adding an experimental flu prevention drug to its portfolio. The New Jersey-based ...

Merck (MRK) stock achieved a 5-day winning streak, with total gains during this time reaching 6.9%. The company’s market ...

Wolfe upgraded Merck to Outperform from Peer Perform and set a $135 price target, saying the drugmaker is approaching a new ...

Rising shares of Merck & Co. and Boeing Co. were helping turn around the Dow Jones Industrial Average in early trading. Drugmaker Merck saw its shares gain 2.5%, leading the blue-chip index higher ...

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...